FRM
ONC

Fox Run Management’s BeOne Medicines Ltd ONC Stock Holding History

Fox Run Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$607K Buy
+2,136
New +$691K 0.11% 358
2025
Q4 		– Sell
-2,058
Closed -$701K – 1335
2025
Q3 		$701K Buy
2,058
+8
+0.4% +$2.43K 0.11% 352
2025
Q2 		$496K Buy
+2,050
New +$503K 0.08% 468
2024
Q1 		– Sell
-2,253
Closed -$406K – 1114
2023
Q4 		$406K Buy
+2,253
New +$408K 0.1% 374
2020
Q2 		– Sell
-1,753
Closed -$216K – 326
2020
Q1 		$216K Buy
+1,753
New +$274K 0.51% 72
2018
Q3 		– Sell
-4,902
Closed -$754K – 864
2018
Q2 		$754K Buy
+4,902
New +$874K 0.24% 114

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return